160 related articles for article (PubMed ID: 29940625)
1. Modern molecular study of weight gain related to antidepressant treatment: clinical implications of the pharmacogenetic testing.
Ageu LŞ; Levai CM; Andreescu NI; Grigoraş ML; Hogea LM; Chiriac DV; Folescu R; Bredicean AC; Nussbaum LM; Enătescu VR; Poroch V; Lupu V; Puiu M; Nussbaum LA
Rom J Morphol Embryol; 2018; 59(1):165-173. PubMed ID: 29940625
[TBL] [Abstract][Full Text] [Related]
2. Molecular study of weight gain related to atypical antipsychotics: clinical implications of the CYP2D6 genotype.
Nussbaum LA; Dumitraşcu V; Tudor A; Grădinaru R; Andreescu N; Puiu M
Rom J Morphol Embryol; 2014; 55(3):877-84. PubMed ID: 25329115
[TBL] [Abstract][Full Text] [Related]
3. [Metabolic side effects of risperidone in early onset schizophrenia].
Goeb JL; Marco S; Duhamel A; Kechid G; Bordet R; Thomas P; Delion P; Jardri R
Encephale; 2010 Jun; 36(3):242-52. PubMed ID: 20620267
[TBL] [Abstract][Full Text] [Related]
4. Integrative clinico-biological, pharmacogenetic, neuroimagistic, neuroendocrinological and psychological correlations in depressive and anxiety disorders.
Hogea LM; Nussbaum LA; Chiriac DV; Ageu LŞ; Andreescu NI; Grigoraş ML; Folescu R; Bredicean AC; Puiu M; Roşca ECI; Simu MA; Levai CM
Rom J Morphol Embryol; 2017; 58(3):767-775. PubMed ID: 29250653
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenetics of psychotropic drug response.
Malhotra AK; Murphy GM; Kennedy JL
Am J Psychiatry; 2004 May; 161(5):780-96. PubMed ID: 15121641
[TBL] [Abstract][Full Text] [Related]
6. [The relationship of cytochrome P450 isoforms with the efficacy and safety of antipsychotic and antidepressant therapy].
Bairamova SP; Pavlova OV; Shport SV; Gurina OI; Pavlov KA
Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(11):40-46. PubMed ID: 37994887
[TBL] [Abstract][Full Text] [Related]
7. The AmpliChip CYP450 genotyping test: Integrating a new clinical tool.
de Leon J; Susce MT; Murray-Carmichael E
Mol Diagn Ther; 2006; 10(3):135-51. PubMed ID: 16771600
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenetic study of second-generation antipsychotic long-term treatment metabolic side effects (the SLiM Study): rationale, objectives, design and sample description.
Pina-Camacho L; Díaz-Caneja CM; Saiz PA; Bobes J; Corripio I; Grasa E; Rodriguez-Jimenez R; Fernández M; Sanjuán J; García-López A; Tapia-Casellas C; Álvarez-Blázquez M; Fraguas D; Mitjans M; Arias B; Arango C
Rev Psiquiatr Salud Ment; 2014; 7(4):166-78. PubMed ID: 25440735
[TBL] [Abstract][Full Text] [Related]
9. The effect of antidepressants and antipsychotics on weight gain in children and adolescents.
Reekie J; Hosking SP; Prakash C; Kao KT; Juonala M; Sabin MA
Obes Rev; 2015 Jul; 16(7):566-80. PubMed ID: 26016407
[TBL] [Abstract][Full Text] [Related]
10. Genetics and personalized medicine in antidepressant treatment.
Gvozdic K; Brandl EJ; Taylor DL; Müller DJ
Curr Pharm Des; 2012; 18(36):5853-78. PubMed ID: 22681166
[TBL] [Abstract][Full Text] [Related]
11. Antidepressant Medications and Weight Change: A Narrative Review.
Gill H; Gill B; El-Halabi S; Chen-Li D; Lipsitz O; Rosenblat JD; Van Rheenen TE; Rodrigues NB; Mansur RB; Majeed A; Lui LMW; Nasri F; Lee Y; Mcintyre RS
Obesity (Silver Spring); 2020 Nov; 28(11):2064-2072. PubMed ID: 33022115
[TBL] [Abstract][Full Text] [Related]
12. Insight gained from genome-wide interaction and enrichment analysis on weight gain during citalopram treatment.
Corfitsen HT; Drago A
Neurosci Lett; 2017 Jan; 637():38-43. PubMed ID: 27899308
[TBL] [Abstract][Full Text] [Related]
13. Individualized medicine - implementation of pharmacogenetic diagnostics in antidepressant drug treatment of major depressive disorders.
Kirchheiner J; Bertilsson L; Bruus H; Wolff A; Roots I; Bauer M
Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S235-43. PubMed ID: 14677085
[TBL] [Abstract][Full Text] [Related]
14. The role of pharmacogenetics in the treatment of depression and anxiety disorders.
Schosser A; Kasper S
Int Clin Psychopharmacol; 2009 Nov; 24(6):277-88. PubMed ID: 19738481
[TBL] [Abstract][Full Text] [Related]
15. Clinical risk factors for weight gain during psychopharmacologic treatment of depression: results from 2 large German observational studies.
Kloiber S; Domschke K; Ising M; Arolt V; Baune BT; Holsboer F; Lucae S
J Clin Psychiatry; 2015 Jun; 76(6):e802-8. PubMed ID: 26132689
[TBL] [Abstract][Full Text] [Related]
16. Pharmacogenetics in Child and Adolescent Psychiatry: Background and Evidence-Based Clinical Applications.
Malik S; Verma P; Ruaño G; Al Siaghy A; Dilawar A; Bishop JR; Strawn JR; Namerow LB
J Child Adolesc Psychopharmacol; 2024 Feb; 34(1):4-20. PubMed ID: 38377525
[TBL] [Abstract][Full Text] [Related]
17. Pharmacogenetics of antidepressant drugs: State of the art and clinical implementation - recommendations from the French National Network of Pharmacogenetics.
Quaranta S; Dupouey J; Colle R; Verstuyft C
Therapie; 2017 Apr; 72(2):311-318. PubMed ID: 28237405
[TBL] [Abstract][Full Text] [Related]
18. Genetic dissection of atypical antipsychotic-induced weight gain: novel preliminary data on the pharmacogenetic puzzle.
Basile VS; Masellis M; McIntyre RS; Meltzer HY; Lieberman JA; Kennedy JL
J Clin Psychiatry; 2001; 62 Suppl 23():45-66. PubMed ID: 11603885
[TBL] [Abstract][Full Text] [Related]
19. Pharmacogenetic insights into depression and antidepressant response: does sex matter?
Pitychoutis PM; Zisaki A; Dalla C; Papadopoulou-Daifoti Z
Curr Pharm Des; 2010; 16(20):2214-23. PubMed ID: 20459391
[TBL] [Abstract][Full Text] [Related]
20. A record linkage study of antidepressant medication use and weight change in Australian adults.
Paige E; Korda R; Kemp-Casey A; Rodgers B; Dobbins T; Banks E
Aust N Z J Psychiatry; 2015 Nov; 49(11):1029-39. PubMed ID: 26427511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
